Understanding the effects of COVID-19 vaccines on patients with autoimmune diseases
Evaluating Clinical and Immunological Consequences of SARS-CoV-2 Vaccination in Rheumatic Disease
This study is looking at how COVID-19 vaccines affect people with autoimmune diseases like rheumatoid arthritis and systemic sclerosis, to see how well the vaccine works for them and if it might cause any issues with their condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pittsburgh at Pittsburgh NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10793472 on NIH RePORTER |
What this research studies
This research investigates how SARS-CoV-2 vaccination impacts patients with autoimmune diseases, such as rheumatoid arthritis and systemic sclerosis. It focuses on the immune responses generated by the vaccine and the potential risks of exacerbating existing autoimmune conditions or triggering new ones. By analyzing the relationship between vaccine-induced antibodies and autoimmune responses, the study aims to fill the knowledge gap left by previous vaccine trials that excluded these patient populations. Participants will be monitored for their immune responses and any changes in their autoimmune status following vaccination.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with autoimmune diseases such as rheumatoid arthritis, systemic sclerosis, or idiopathic inflammatory myopathy.
Not a fit: Patients without autoimmune diseases or those who are not receiving SARS-CoV-2 vaccinations may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved vaccination strategies for patients with autoimmune diseases, ensuring their safety and health.
How similar studies have performed: While there is ongoing research into vaccine responses in autoimmune patients, this specific investigation into SARS-CoV-2 vaccination effects is relatively novel.
Where this research is happening
Pittsburgh, United States
- University of Pittsburgh at Pittsburgh — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Domsic, Robyn Therese — University of Pittsburgh at Pittsburgh
- Study coordinator: Domsic, Robyn Therese
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.